Role of oxidative stress in thyroid hormone-induced cardiomyocyte hypertrophy and associated cardiac dysfunction: An undisclosed story

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Elnakish, Mohammad T ^a,b,c   Ahmed, Amany A E ^c   Mohler, Peter J ^a,b   Janssen, Paul M L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c Helwan   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CARDIOLOGY; HORMONES; MOBILE SECURITY; OXIDATIVE STRESS; PATHOLOGY;

ANTIOXIDANT TREATMENT; CARDIAC HYPERTROPHY; ENDOCRINE DISORDERS; EXPERIMENTAL ANIMALS; LEFT VENTRICLES; MOLECULAR CHANGES; REACTIVE OXYGEN SPECIES; THYROID HORMONES;

HEART;

ANTIOXIDANT; THYROID HORMONE; REACTIVE OXYGEN METABOLITE;

CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL SURVIVAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DNA DAMAGE; EXPERIMENTAL HYPERTHYROIDISM; EXPERIMENTAL MODEL; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTHYROIDISM; NONHUMAN; OXIDATIVE STRESS; REVIEW; THYROTOXICOSIS; TISSUE INJURY; TISSUE REPAIR; ANIMAL; CARDIAC MUSCLE; CARDIOMEGALY; COMPLICATION; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALIA;

ANIMALS; ANTIOXIDANTS; CARDIOMEGALY; HEART VENTRICLES; HYPERTHYROIDISM; MYOCARDIUM; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; THYROID HORMONES;

EID: 84935002164     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/854265     Document Type: Review

References (119)

1. M. T. Elnakish, H. H. Hassanain, P. M. Janssen, M. G. Angelos, and M. Khan, "Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase," Journal of Pathology, vol. 231, no. 3, pp. 290-300, 2013.
2. M. S. Petrulea, I. Duncea, and A. Muresan, "Tyroid hormones in excess induce oxidative stress in rats," Acta Endocrinologica, vol. 5, no. 2, pp. 155-164, 2009.
3. M. Messarah, M. S. Boulakoud, A. Boumendjel, C. Abdennour, and A. El Feki, "The impact of thyroid activity variations on some oxidizing-stress parameters in rats," Comptes Rendus Biologies, vol. 330, no. 2, pp. 107-112, 2007.
4. J. Nordberg and E. S. J. Arnér, "Reactive oxygen species, anti-oxidants, and the mammalian thioredoxin system," Free Radical Biology and Medicine, vol. 31, no. 11, pp. 1287-1312, 2001.
5. H. Sies, "Oxidative stress: oxidants and antioxidants," Experimental Physiology, vol. 82, no. 2, pp. 291-295, 1997.
6. B. C. Freeman and J. D. Crapo, "Biology of disease. Free radicals and tissue injury," Laboratory Investigation, vol. 47, no. 5, pp. 412-426, 1982.
7. B. Halliwell and J. M. C. Gutteridge, "Role of free radicals and catalytic metal ions in human disease: an overview," Methods in Enzymology, vol. 186, pp. 1-85, 1990.
8. K. Asayama and K. Kato, "Oxidative muscular injury and its relevance to hyperthyroidism," Free Radical Biology and Medicine, vol. 8, no. 3, pp. 293-303, 1990.
9. I. Villanueva, C. Alva-Sánchez, and J. Pacheco-Rosado, "The role of thyroid hormones as inductors of oxidative stress and neurodegeneration," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 218145, 15 pages, 2013.
10. K. De, G. Ghosh, M. Datta et al., "Analysis of diferentially expressed genes in hyperthyroid-induced hypertrophied heart by cDNA microarray," The Journal of Endocrinology, vol. 182, no. 2, pp. 303-314, 2004.
11. I. Klein and S. Danzi, "Tyroid disease and the heart," Circulation, vol. 116, no. 15, pp. 1725-1735, 2007.
12. J. A. Kuzman, K. A. Vogelsang, T. A. Tomas, and A. M. Gerdes, "L-Tyroxine activates Akt signaling in the heart," Journal of Molecular and Cellular Cardiology, vol. 39, no. 2, pp. 251-258, 2005.
13. H. Degens, A. J. Gilde, M. Lindhout, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen, "Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment," American Journal of Physiology-Heart and Circulatory Physiology, vol. 284, no. 1, pp. H108-H115, 2003.
14. R. Gredilla, G. Barja, and M. López-Torres, "Tyroid hormone-induced oxidative damage on lipids, glutathione and DNA in the mouse heart," Free Radical Research, vol. 35, no. 4, pp. 417-425, 2001.
15. M. T. Elnakish, M. M. Awad, M. D. H. Hassona et al., "Cardiac remodeling caused by transgenic overexpression of a corn Rac gene," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 301, no. 3, pp. H868-H880, 2011.
16. M. T. Elnakish, M. D. H. Hassona, M. A. Alhaj et al., "Rac-induced lef ventricular dilation in thyroxin-treated zmracd transgenic mice: role of cardiomyocyte apoptosis and myocar-dial fbrosis," PLoS ONE, vol. 7, no. 8, Article ID e42500, 2012.
17. M. T. Elnakish, L. Moldovan, M. Khan, H. H. Hassanain, and P. M. L. Janssen, "Myocardial Rac1 exhibits partial involvement in thyroxin-induced cardiomyocyte hypertrophy and its inhibition is not sufcient to improve cardiac dysfunction or contractile abnormalities in mouse papillary muscles," Journal of Cardiovascular Pharmacology, vol. 61, no. 6, pp. 536-544, 2013.
18. A. S. R. Araujo, M. F. M. Ribeiro, A. Enzveiler et al., "Myocar-dial antioxidant enzyme activities and concentration and glu-tathione metabolism in experimental hyperthyroidism," Molecular and Cellular Endocrinology, vol. 249, no. 1-2, pp. 133-139, 2006.
19. A. S. R. Araujo, A. T. Enzveiler, P. Schenkel et al., "Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyrox-ine," Molecular and Cellular Biochemistry, vol. 303, no. 1-2, pp. 89-95, 2007.
20. A. S. R. Araujo, P. Schenkel, A. T. Enzveiler et al., "The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism," Journal of Molecular Endocrinology, vol. 41, no. 5-6, pp. 423-430, 2008.
21. J. A. Kuzman, T. A. Tomas, K. A. Vogelsang, S. Said, B. E. Anderson, and A. M. Gerdes, "Efects of induced hyperthy-roidism in normal and cardiomyopathic hamsters," Journal of Applied Physiology, vol. 99, no. 4, pp. 1428-1433, 2005.
22. A. S. R. Araujo, T. Fernandes, M. F. Ribeiro, N. Khaper, and A. Belló-Klein, "Redox regulation of myocardial Erk 1/2 phospho-rylation in experimental hyperthyroidism: role of thioredoxin-peroxiredoxin system," Journal of Cardiovascular Pharmacology, vol. 56, no. 5, pp. 513-517, 2010.
23. A. S. R. Araujo, G. P. Diniz, F. E. R. Seibel et al., "Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system," Molecular and Cellular Endocrinology, vol. 333, no. 1, pp. 78-84, 2011.
24. R. O. Fernandes, G. J. Dreher, P. C. Schenkel et al., "Redox status and pro-survival/pro-apoptotic protein expression in the early cardiac hypertrophy induced by experimental hyperthy-roidism," Cell Biochemistry and Function, vol. 29, no. 7, pp. 617-623, 2011.
25. K. Asayama, K. Dobashi, H. Hayashibe, and K. Kato, "Vitamin E protects against thyroxine-induced acceleration of lipid peroxidation in cardiac and skeletal muscles in rats," Journal of Nutritional Science and Vitaminology, vol. 35, no. 5, pp. 407-418, 1989.
26. J. M. Moreno, I. Rodríguez Gómez, R. Wangensteen, A. Osuna, P. Bueno, and F. Vargas, "Cardiac and renal antioxidant enzymes and efects of tempol in hyperthyroid rats," The American Journal of Physiology-Endocrinology and Metabolism, vol. 289, no. 5, pp. E776-E783, 2005.
27. I. Rodríguez-Gómez, J. Sainz, R. Wangensteen et al., "Increased pressor sensitivity to chronic nitric oxide defciency in hyper-thyroid rats," Hypertension, vol. 42, no. 2, pp. 220-225, 2003.
28. I. Rodríguez-Gómez, R. Wangensteen, J. M. Moreno, V. Cham-orro, A. Osuna, and F. Vargas, "Efects of chronic inhibition of inducible nitric oxide synthase in hyperthyroid rats," American Journal of Physiology-Endocrinology and Metabolism, vol. 288, no. 6, pp. E1252-E1257, 2005.
29. R. Wangensteen, I. Rodríguez-Gómez, J. M. Moreno, M. Álvarez-Guerra, A. Osuna, and F. Vargas, "Efects of chronic treatment with 7-nitroindazole in hyperthyroid rats," The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 291, no. 5, pp. R1376-R1382, 2006.
30. K. Riaz, A. D. Forker, W. L. Isley, M. S. Hamburg, and P. A. McCullough, "Hyperthyroidism: a 'curable' cause of congestive heart failure-three case reports and a review of the literature," Congestive Heart Failure, vol. 9, no. 1, pp. 40-46, 2003.
31. G. E. Umpierrez, S. Challapalli, and C. Patterson, "Congestive heart failure due to reversible cardiomyopathy in patients with hyperthyroidism," The American Journal of the Medical Sciences, vol. 310, no. 3, pp. 99-102, 1995.
32. L. E. A. Wildemberg, L. L. de Sousa, L. P. M. da Fonseca, and M. V. L. de Souza, "Reversible dilated cardiomyopathy related to hyperthyroidism," Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 51, no. 9, pp. 1533-1538, 2007.
33. V. M. Rodríguez Blanco, V. Barriales Álvarez, E. Segovia Martínez, C. M. de la Tassa, R. Barriales Villa, and A. C. Llosa, "Reversible dilated cardiomyopathy and thyrotoxicosis," Revista Española de Cardiologí a, vol. 49, no. 10, pp. 770-772, 1996.
34. R. W. Tsika, J. J. Bahl, L. A. Leinwand, and E. Morkin, "Tyroid hormone regulates expression of a transfected human β-myosin heavy-chain fusion gene in fetal rat heart cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 1, pp. 379-383, 1990.
35. 2+-ATPas e gene," The Journal of Biological Chemistry, vol. 269, no. 2, pp. 1460-1467, 1994.
36. J. Orlowski and J. B. Lingrel, "Tyroid and glucocorticoid hormones regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes," The Journal of Biological Chemistry, vol. 265, no. 6, pp. 3462-3470, 1990.
37. S. W. Bahouth, "Tyroid hormones transcriptionally regulate the β1-adrenergic receptor gene in cultured ventricular myocytes," The Journal of Biological Chemistry, vol. 266, no. 24, pp. 15863-15869, 1991.
38. M. J. Fullerton, S. Stuchbury, Z. S. Krozowski, and J. W. Funder, "Altered thyroidal status and the in vivo synthesis of atrial natriuretic peptide in the rat heart," Molecular and Cellular Endocrinology, vol. 69, no. 2-3, pp. 227-233, 1990.
39. V. Averyhart-Fullard, L. D. Fraker, A. M. Murphy, and R. J. Solaro, "Diferential regulation of slow-skeletal and cardiac troponin I mRNA during development and by thyroid hormone in rat heart," Journal of Molecular and Cellular Cardiology, vol. 26, no. 5, pp. 609-616, 1994.
40. E. Morkin, "Regulation of myosin heavy chain genes in the heart," Circulation, vol. 87, no. 5, pp. 1451-1460, 1993.
41. P. Mishra and L. Samanta, "Oxidative stress and heart failure in altered thyroid states," The Scientifc World Journal, vol. 2012, Article ID 741861, 17 pages, 2012.
42. 3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis," Endocrinology, vol. 146, no. 7, pp. 2864-2871, 2005.
43. K. Asayama, K. Dobashi, H. Hayashibe, Y. Megata, and K. Kato, "Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism," Endocrinology, vol. 121, no. 6, pp. 2112-2118, 1987.
44. K. Asayama, K. Dobashi, H. Hayashibe, and K. Kato, "Efects of beta-adrenergic blockers with diferent ancillary properties on lipid peroxidation in hyperthyroid rat cardiac muscle," Endocrinologia Japonica, vol. 36, no. 5, pp. 687-694, 1989.
45. R. Shinohara, T. Mano, A. Nagasaka et al., "Lipid peroxidation levels in rat cardiac muscle are afected by age and thyroid status," The Journal of Endocrinology, vol. 164, no. 1, pp. 97-102, 2000.
46. T. Mano, R. Sinohara, Y. Sawai et al., "Efects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle," Journal of Endocrinology, vol. 145, no. 1, pp. 131-136, 1995.
47. S. Civelek, O. Seymen, A. Seven, G. Yiʇit, H. Hatemi, and G. Burçak, "Oxidative stress in heart tissue of hyperthyroid and iron supplemented rats," Journal of Toxicology and Environmental Health, Part A, vol. 64, no. 6, pp. 499-506, 2001.
48. P. Venditti, M. Balestrieri, S. di Meo, and T. de Leo, "Efect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues," The Journal of Endocrinology, vol. 155, no. 1, pp. 151-157, 1997.
49. R. Mogulkoc, A. K. Baltaci, L. Aydin, E. Oztekin, and A. Sivrikaya, "The efect of thyroxine administration on lipid peroxidation in diferent tissues of rats with hypothyroidism," Acta Physiologica Hungarica, vol. 92, no. 1, pp. 39-46, 2005.
50. A. M. Mohamadin, L. N. A. Hammad, M. F. El-Bab, and H. S. Abdel Gawad, "Attenuation of oxidative stress in plasma and tissues of rats with experimentally induced hyperthyroidism by cafeic acid phenylethyl ester," Basic & Clinical Pharmacology & Toxicology, vol. 100, no. 2, pp. 84-90, 2007.
51. S. Ikeda, N. Hamada, H. Morii, M. Inaba, and J. Yamakawa, "Serum and tissue coenzyme Q9 in rats with thyroid dysfunctions," Hormone and Metabolic Research, vol. 16, no. 11, pp. 585-588, 1984.
52. P. Venditti, T. De Leo, and S. Di Meo, "Vitamin E administration attenuates the tri-iodothyronine-induced modifcation of heart electrical activity in the rat," The Journal of Experimental Biology, vol. 200, no. 5, pp. 909-914, 1997.
53. P. Venditti, T. de Leo, and S. di Meo, "Antioxidant-sensitive shortening of ventricular action potential in hyperthyroid rats is independent of lipid peroxidation," Molecular and Cellular Endocrinology, vol. 142, no. 1-2, pp. 15-23, 1998.
54. P. Venditti and S. di Meo, "Tyroid hormone-induced oxidative stress," Cellular and Molecular Life Sciences, vol. 63, no. 4, pp. 414-434, 2006.
55. T. Yamada, T. Mishima, M. Sakamoto, M. Sugiyama, S. Mat-sunaga, and M. Wada, "Myofbrillar protein oxidation and contractile dysfunction in hyperthyroid rat diaphragm," Journal of Applied Physiology, vol. 102, no. 5, pp. 1850-1855, 2007.
56. M. T. Elnakish, E. J. Schultz, R. L. Gearinger et al., "Diferential involvement of various sources of reactive oxygen species in thyroxin-induced hemodynamic changes and contractile dysfunction of the heart and diaphragm muscles," Free Radical Biology and Medicine, vol. 83, pp. 252-261, 2015.
57. T. Ide, H. Tsutsui, S. Kinugawa et al., "Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium," Circulation Research, vol. 86, no. 2, pp. 152-157, 2000.
58. T. Ide, H. Tsutsui, S. Hayashidani et al., "Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts afer myocardial infarction," Circulation Research, vol. 88, no. 5, pp. 529-535, 2001.
59. K. Nishiki, M. Erecinska, D. F. Wilson, and S. Cooper, "Evaluation of oxidative phosphorylation in hearts from euthyroid, hypothyroid, and hyperthyroid rats," The American Journal of Physiology-Cell Physiology, vol. 4, no. 3, pp. C212-C219, 1978.
60. J. F. Turrens, A. Alexandre, and A. L. Lehninger, "Ubisemiquin-one is the electron donor for superoxide formation by complex III of heart mitochondria," Archives of Biochemistry and Biophysics, vol. 237, no. 2, pp. 408-414, 1985.
61. B. Chance, H. Sies, and A. Boveris, "Hydroperoxide metabolism in mammalian organs," Physiological Reviews, vol. 59, no. 3, pp. 527-605, 1979.
62. A. Mutvei, S. Kuzela, and B. D. Nelson, "Control of mitochon-drial transcription by thyroid hormone," European Journal of Biochemistry, vol. 180, no. 1, pp. 235-240, 1989.
63. P. D. M. Rosaroll, V. Di Maio, M. Valente, S. Di Meo, and T. de Leo, "Tyroid hormone and the mitochondrial population in the rat heart," Journal of Endocrinological Investigation, vol. 11, no. 8, pp. 559-565, 1988.
64. S. Di Meo, P. de Martino Rosaroll, and T. De Leo, "Efect of thyroid state on the morphofunctional properties of heart mitochondria," Cellular Physiology and Biochemistry, vol. 2, no. 5, pp. 283-292, 1992.
65. E. Novo and M. Parola, "Redox mechanisms in hepatic chronic wound healing and fbrogenesis," Fibrogenesis & Tissue Repair, vol. 1, no. 1, article 5, 2008.
66. D. Baraldi, K. Casali, R. O. Fernandes et al., "The role of AT1-receptor blockade on reactive oxygen species and cardiac autonomic drive in experimental hyperthyroidism," Autonomic Neuroscience: Basic and Clinical, vol. 177, no. 2, pp. 163-169, 2013.
67. P. Pacher, R. Schulz, L. Liaudet, and C. Szabó, "Nitrosative stress and pharmacological modulation of heart failure," Trends in Pharmacological Sciences, vol. 26, no. 6, pp. 302-310, 2005.
68. U. Landmesser, S. Dikalov, S. R. Price et al., "Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension," The Journal of Clinical Investigation, vol. 111, no. 8, pp. 1201-1209, 2003.
69. E. Takimoto, H. C. Champion, M. Li et al., "Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load," The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1221-1231, 2005.
70. P. Masullo, P. Venditti, C. Agnisola, and S. di Meo, "Role of nitric oxide in the reperfusion induced injury in hyperthyroid rat hearts," Free Radical Research, vol. 32, no. 5, pp. 411-421, 2000.
71. P. Venditti, R. de Rosa, L. Cigliano, C. Agnisola, and S. Di Meo, "Role of nitric oxide in the functional response to ischemia-reperfusion of heart mitochondria from hyperthyroid rats," Cellular and Molecular Life Sciences, vol. 61, no. 17, pp. 2244-2252, 2004.
72. A. Quesada, J. Sainz, R. Wangensteen, I. Rodriguez-Gomez, F. Vargas, and A. Osuna, "Nitric oxide synthase activity in hyperthyroid and hypothyroid rats," European Journal of Endocrinology, vol. 147, no. 1, pp. 117-122, 2002.
73. A. L. Fellet, P. Arza, N. Arreche, C. Arranz, and A. M. Balaszczuk, "Nitric oxide and thyroid gland: modulation of cardiovascular function in automatic-blocked anaesthetized rats," Experimental Physiology, vol. 89, no. 3, pp. 303-312, 2004.
74. T. Ukai, C.-P. Cheng, H. Tachibana et al., "Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure," Circulation, vol. 103, no. 5, pp. 750-755, 2001.
75. U. E. G. Ekelund, R. W. Harrison, O. Shokek et al., "Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efciency in dogs with pacing-induced heart failure," Circulation Research, vol. 85, no. 5, pp. 437-445, 1999.
76. T. P. Cappola, D. A. Kass, G. S. Nelson et al., "Allopurinol improves myocardial efciency in patients with idiopathic dilated cardiomyopathy," Circulation, vol. 104, no. 20, pp. 2407-2411, 2001.
77. K. Huh, T.-H. Kwon, J.-S. Kim, and J. M. Park, "Role of the hepatic xanthine oxidase in thyroid dysfunction: efect of thyroid hormones in oxidative stress in rat liver," Archives of Pharmacal Research, vol. 21, no. 3, pp. 236-240, 1998.
78. L. Bartalena, M. L. Tanda, E. Piantanida, and A. Lai, "Oxidative stress and Graves' ophthalmopathy: in vitro studies and therapeutic implications," BioFactors, vol. 19, no. 3-4, pp. 155-163, 2003.
79. E. A. Bouzas, P. Karadimas, G. Mastorakos, and D. A. Koutras, "Antioxidant agents in the treatment of Graves' ophthalmopa-thy," American Journal of Ophthalmology, vol. 129, no. 5, pp. 618-622, 2000.
80. J. Kawada, Y. Shirakawa, Y. Yoshimura, and M. Nishida, "Ty-roid xanthine oxidase and its role in thyroid iodine metabolism in the rat: diference between efects of allopurinol and tungstate," The Journal of Endocrinology, vol. 95, no. 1, pp. 117-124, 1982.
81. O. Makay, C. Yenisey, G. Icoz et al., "The role of allopurinol on oxidative stress in experimental hyperthyroidism," Journal of Endocrinological Investigation, vol. 32, no. 8, pp. 641-646, 2009.
82. N. Aspromonte, F. Monitillo, A. Puzzovivo, R. Valle, P. Cal-darola, and M. Iacoviello, "Modulation of cardiac cytochrome P450 in patients with heart failure," Expert Opinion on Drug Metabolism and Toxicology, vol. 10, no. 3, pp. 327-339, 2014.
83. A. A. El-Sherbeni and A. O. S. El-Kadi, "Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy," Biochemical Pharmacology, vol. 87, no. 3, pp. 456-466, 2014.
84. A. Adameova, Y. Abdellatif, and N. S. Dhalla, "Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease," Canadian Journal of Physiology and Pharmacology, vol. 87, no. 7, pp. 493-514, 2009.
85. G. S. Levey, "Catecholamine sensitivity, thyroid hormone and the heart, a reevaluation," The American Journal of Medicine, vol. 50, no. 4, pp. 413-420, 1971.
86. L. W. Hu, L. A. Benvenuti, E. A. Liberti, M. S. Carneiro-Ramos, and M. L. M. Barreto-Chaves, "Tyroxine-induced cardiac hypertrophy: infuence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling," American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 285, no. 6, pp. R1473-R1480, 2003.
87. A. M. Gerdes, J. A. Moore, and S. P. Bishop, "Failure of propranolol to prevent chronic hyperthyroid induced cardiac hypertrophy and multifocal cellular necrosis in the rat," The Canadian Journal of Cardiology, vol. 1, no. 5, pp. 340-345, 1985.
88. I. Klein, "Tyroxine-induced cardiac hypertrophy: time course of development and inhibition by propranolol," Endocrinology, vol. 123, no. 1, pp. 203-210, 1988.
89. M. López-Torres, M. Romero, and G. Barja, "Efect of thyroid hormones on mitochondrial oxygen free radical production and DNA oxidative damage in the rat heart," Molecular and Cellular Endocrinology, vol. 168, no. 1-2, pp. 127-134, 2000.
90. C. Richter, J.-W. Park, and B. N. Ames, "Normal oxidative damage to mitochondrial and nuclear DNA is extensive," Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 17, pp. 6465-6467, 1988.
91. R. Lu, H. M. Nash, and G. L. Verdine, "A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer," Current Biology, vol. 7, no. 6, pp. 397-407, 1997.
92. R. Yamaguchi, T. Hirano, S. Asami, A. Sugita, and H. Kasai, "Increase in the 8-hydroxyguanine repair activity in the rat kidney afer the administration of a renal carcinogen, ferric nitrilotriacetate," Environmental Health Perspectives, vol. 104, no. 3, pp. 651-653, 1996.
93. F. J. Giordano, "Oxygen, oxidative stress, hypoxia, and heart failure," The Journal of Clinical Investigation, vol. 115, no. 3, pp. 500-508, 2005.
94. Y. Wang, B. Jiao, W. Guo, H. Che, and Z. Yu, "Excessive thyrox-ine enhances susceptibility to apoptosis and decreases contractility of cardiomyocytes," Molecular and Cellular Endocrinology, vol. 320, no. 1-2, pp. 67-75, 2010.
95. K. Itoh, K. I. Tong, and M. Yamamoto, "Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles," Free Radical Biology and Medicine, vol. 36, no. 10, pp. 1208-1213, 2004.
96. S. E. Purdom-Dickinson, E. V. Sheveleva, H. Sun, and Q. M. Chen, "Translational control of Nrf2 protein in activation of antioxidant response by oxidants," Molecular Pharmacology, vol. 72, no. 4, pp. 1074-1081, 2007.
97. T. Satoh, N. Harada, T. Hosoya, K. Tohyama, M. Yamamoto, and K. Itoh, "Keap1/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice," Biochemical and Biophysical Research Communications, vol. 380, no. 2, pp. 298-302, 2009.
98. D. Trachootham, W. Lu, M. A. Ogasawara, N. R.-D. Valle, and P. Huang, "Redox regulation of cell survival," Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343-1374, 2008.
99. 2 involves KEAP1 disulfde formation," The Journal of Biological Chemistry, vol. 285, no. 11, pp. 8463-8471, 2010.
100. M. Yamamoto, G. Yang, C. Hong et al., "Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy," The Journal of Clinical Investigation, vol. 112, no. 9, pp. 1395-1406, 2003.
101. R. J. Arai, F. T. Ogata, W. L. Batista et al., "Tioredoxin-1 promotes survival in cells exposed to S-nitrosoglutathione: correlation with reduction of intracellular levels of nitrosothiols and up-regulation of the ERK1/2 MAP Kinases," Toxicology and Applied Pharmacology, vol. 233, no. 2, pp. 227-237, 2008.
102. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease," International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
103. P. Kaur, G. Kaur, and M. P. Bansal, "Upregulation of AP1 by tertiary butyl hydroperoxide induced oxidative stress and subsequent efect on spermatogenesis in mice testis," Molecular and Cellular Biochemistry, vol. 308, no. 1-2, pp. 177-181, 2008.
104. D. K. Das, N. Maulik, and R. M. Engelman, "Redox regulation of angiotensin II signaling in the heart," Journal of Cellular and Molecular Medicine, vol. 8, no. 1, pp. 144-152, 2004.
105. C. L. Antos, T. A. McKinsey, N. Frey et al., "Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 2, pp. 907-912, 2002.
106. A. Kenessey and K. Ojamaa, "Tyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways," The Journal of Biological Chemistry, vol. 281, no. 30, pp. 20666-20672, 2006.
107. H. Kobori, A. Ichihara, H. Suzuki et al., "Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 273, no. 2, pp. H593-H599, 1997.
108. H. Kobori, A. Ichihara, H. Suzuki, Y. Miyashita, M. Hayashi, and T. Saruta, "Tyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system," American Journal of Physiology: Endocrinology and Metabolism, vol. 272, no. 2, pp. E227-E232, 1997.
109. M. S. Carneiro-Ramos, G. P. Diniz, A. P. Nadu et al., "Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation," Basic Research in Cardiology, vol. 105, no. 3, pp. 325-335, 2010.
110. Y. J. Suzuki, "Growth factor signaling for cardioprotection against oxidative stress-induced apoptosis," Antioxidants & Redox Signaling, vol. 5, no. 6, pp. 741-749, 2003.
111. F. Wang, Q. He, Y. Sun, X. Dai, and X. P. Yang, "Female adult mouse cardiomyocytes are protected against oxidative stress," Hypertension, vol. 55, no. 5, pp. 1172-1178, 2010.
112. R. Aikawa, I. Komuro, T. Yamazaki et al., "Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats," The Journal of Clinical Investigation, vol. 100, no. 7, pp. 1813-1821, 1997.
113. A. Seven, O. Seymen, S. Hatemi, H. Hatemi, G. Yiʇit, and G. Candan, "Antioxidant status in experimental hyperthyroidism: efect of vitamin E supplementation," Clinica Chimica Acta, vol. 256, no. 1, pp. 65-74, 1996.
114. M. Wang, J. Zhang, S. J. Walker, R. Dworakowski, E. G. Lakatta, and A. M. Shah, "Involvement of NADPH oxidase in age-associated cardiac remodeling," Journal of Molecular and Cellular Cardiology, vol. 48, no. 4, pp. 765-772, 2010.
115. F. Haddad, S. A. Hunt, D. N. Rosenthal, and D. J. Murphy, "Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle," Circulation, vol. 117, no. 11, pp. 1436-1448, 2008.
116. Y. Hiroi, K. Fujiu, S. Komatsu et al., "Carvedilol therapy improved lef ventricular function in a patient with arrhyth-mogenic right ventricular cardiomyopathy," Japanese Heart Journal, vol. 45, no. 1, pp. 169-177, 2004.
117. D. J. Grieve, J. A. Byrne, A. Siva et al., "Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload," Journal of the American College of Cardiology, vol. 47, no. 4, pp. 817-826, 2006.
118. B. Biondi, "Mechanisms in endocrinology: heart failure and thyroid dysfunction," European Journal of Endocrinology, vol. 167, no. 5, pp. 609-618, 2012.
119. F. Brandt, A. Green, L. Hegedüs, and T. H. Brix, "A critical review and meta-analysis of the association between overt hyperthyroidism and mortality," European Journal of Endocrinology, vol. 165, no. 4, pp. 491-497, 2011.